ChromaDex (CDXC) Misses Q1 EPS by 3c

ChromaDex (NASDAQ: CDXC) reported Q1 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $16.68 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Goldman Sachs Upgrades SK Innovation Co Ltd (096770:KS) to Neutral
• UBS Downgrades Buzzi Unicem SpA (BZU:IM) (BZZUY) to Sell